SEC Form 4 · accession 0001237899-15-000047
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A Poon
Director
Period of report
Aug 11, 2015
Accepted (ET)
Aug 12, 2015 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2015 | M | 470 | $273.67 | A | 1,125 | D | |
| Common Stock | Aug 11, 2015 | F | 223 | $574.57 | D | 902 | D | |
| Common Stock | Aug 12, 2015 | S | 100 | $564.16 | D | 802 | D | |
| Common Stock | Aug 12, 2015 | S | 12 | $564.17 | D | 790 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $273.67 | Aug 11, 2015 | M | 470 | D | — | Jan 2, 2024 | Common Stock | 470 | 12,280 | D |
Explanation of responses
- F1The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.